Scott Greenwald, PhD

Scott-Greenwald

Dr. Scott Greenwald graduated from the University of Pennsylvania with a degree in the biological basis of behavior before joining Second Sight Medical Products to research the perceptual effects of artificial retinal stimulation in patients with advanced retinitis pigmentosa.  He went on to study cone photoreceptor dysfunction associated with inherited retinal diseases at the University of Washington where he earned a PhD in neurobiology.

Scott became a member of the Ocular Genomics Institute in 2013. He is investigating the role of the NMNAT1 enzyme in retinal cell metabolism and the mechanisms by which specific mutations in the NMNAT1 gene lead to an early-onset blinding disease called Leber congenital amaurosis (LCA).

Back to top
Back to top